Kaufmann Michael C
Chief Executive Officer at CAH
- Sold, on record
- $41.9M
- Dollars the filings state
- Form 4 sales
- 14
- Latest Jan 22, 2018
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CAHCARDINAL HEALTH INCChief Executive Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale CAHPlan not statedJul 1, 2011 2011
Sold 10,143 shares at $45.95 ($466k)
Kaufmann Michael C, CEO, Pharmaceutical Segment
Sold 14% of holdings ($3.3M position)62,160 shares left1.1x usual sizeFiling
- 2 Form 4 sale CAHUnusualOct 27, 2011 +118 days
Sold 43,164 shares at $44.95 ($1.9M)
Kaufmann Michael C, CEO, Pharmaceutical Segment
Sold 32.3% of holdings ($6M position)90,646 shares left4.3x usual sizeFiling
- 3 Form 4 sale CAHUnusualJan 23, 2013 +454 days
Sold 58,362 shares at $44.95 ($2.6M)
Kaufmann Michael C, CEO, Pharmaceutical Segment
Sold 35.9% of holdings ($7.3M position)104,330 shares left5.8x usual sizeFiling
- 4 Form 4 sale CAHUnusualMay 22, 2013 +119 days
Sold 36 shares at $47.52 ($2k)
Kaufmann Michael C, CEO, Pharmaceutical Segment
Sold 100% of holdings ($2k position)0 shares left0x usual sizeFiling
- 5 Form 4 sale CAHUnusualFeb 11, 2014 +265 days
Sold 388,995 shares at $67.46 ($26.2M)
Kaufmann Michael C, CEO, Pharmaceutical Segment
Sold 77% of holdings ($34.1M position)115,969 shares leftFiling
- 6 Form 4 sale CAHPlan not statedAug 18, 2014 +188 days
Sold 6,833 shares at $72.06 ($492k)
Kaufmann Michael C, CEO, Pharmaceutical Segment
Sold 5.4% of holdings ($9M position)118,576 shares left0.1x usual sizeFiling
- 7 Form 4 sale CAHUnusualSep 4, 2014 +17 days
Sold 50,216 shares at $74.95 ($3.8M)
Kaufmann Michael C, CEO, Pharmaceutical Segment
Sold 29.8% of holdings ($12.7M position)118,576 shares left1.5x usual sizeFiling
- 8 Form 4 sale CAHPlan not statedJan 22, 2018 +1236 days
Sold 18,586 shares at $73.90 ($1.4M)
Kaufmann Michael C, Chief Executive Officer
Sold 8.1% of holdings ($17M position)211,849 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (14)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 22, 2018 | Jan 23, 2018 | CAH | Chief Executive Officer | Form 4 sale | 18,586 | $1.4M | 8.1% | Plan not stated | SEC |
| Sep 4, 2014 | Sep 5, 2014 | CAH | CEO, Pharmaceutical Segment | Form 4 sale | 50,216 | $3.8M | 29.8% | Unusual | SEC |
| Aug 18, 2014 | Aug 19, 2014 | CAH | CEO, Pharmaceutical Segment | Form 4 sale | 6,833 | $492k | 5.4% | Plan not stated | SEC |
| Feb 11, 2014 | Feb 11, 2014 | CAH | CEO, Pharmaceutical Segment | Form 4 sale | 388,995 | $26.2M | 77.0% | Unusual | SEC |
| May 22, 2013 | May 23, 2013 | CAH | CEO, Pharmaceutical Segment | Form 4 sale | 36 | $2k | 100.0% | Unusual | SEC |
| Jan 23, 2013 | Jan 25, 2013 | CAH | CEO, Pharmaceutical Segment | Form 4 sale | 58,362 | $2.6M | 35.9% | Unusual | SEC |
| Oct 27, 2011 | Oct 28, 2011 | CAH | CEO, Pharmaceutical Segment | Form 4 sale | 43,164 | $1.9M | 32.3% | Unusual | SEC |
| Jul 1, 2011 | Jul 5, 2011 | CAH | CEO, Pharmaceutical Segment | Form 4 sale | 10,143 | $466k | 14.0% | Plan not stated | SEC |
| May 5, 2011 | May 9, 2011 | CAH | CEO, Pharmaceutical Segment | Form 4 sale | 10,143 | $456k | 14.0% | Plan not stated | SEC |
| Apr 27, 2011 | Apr 27, 2011 | CAH | CEO, Pharmaceutical Segment | Form 4 sale | 10,143 | $446k | 14.0% | Plan not stated | SEC |
| Apr 21, 2011 | Apr 25, 2011 | CAH | CEO, Pharmaceutical Segment | Form 4 sale | 8,560 | $368k | 12.1% | Unusual | SEC |
| Mar 18, 2011 | Mar 21, 2011 | CAH | CEO, Pharmaceutical Segment | Form 4 sale | 177 | $7k | 0.2% | Plan not stated | SEC |
| Feb 7, 2011 | Feb 8, 2011 | CAH | CEO, Pharmaceutical Segment | Form 4 sale | 87,544 | $3.7M | 55.3% | Unusual | SEC |
| Dec 3, 2010 | Dec 7, 2010 | CAH | CEO, Pharmaceutical Segment | Form 4 sale | 633 | $24k | 100.0% | Unusual | SEC |